242721 ⎘
Vaporized medicants and methods of use
#2Container For Inhalation Anesthetic
#3Vaporized medicants and methods of use
#4Vaporized medicants and methods of use
#5Method of making particles for use in a pharmaceutical composition
#6Vaporized medicants and methods of use
#7Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
#8Vaporized medicants and methods of use
#9Vaporized medicants and methods of use
#10Vaporized medicants and methods of use
#11Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
#12Medicinal aerosols and methods of delivery thereof
#13Dry powder formulations and methods of use
#14Vaporized medicants and methods of use
#15Flow and volume regulated inhalation for treatment of severe oral corticosteroid-dependent asthma
#16Methods for treating nicotine addiction and reducing food consumption
#17USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#18Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
#19CONTAINER FOR INHALATION ANESTHETIC
#20DELIVERY OF DRUG AMINES THROUGH AN INHALATION ROUTE
#21Method for treating a mammal by administration of a compound having the ability to release CO
#22PRESSURISED METERED DOSE INHALERS (MDI)
#23E-selectin compositions and use thereof for inducing E-selectin tolerance
#24METHODS AND UNIT DOSE FORMULATIONS FOR THE INHALATION ADMINISTRATION OF AMINOGLYCOSIDE ANTIBIOTICS
#25Method of making particles for use in a pharmaceutical composition
#26COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#27USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#28Pharmaceutical aerosol composition
#29Respiratory drug condensation aerosols and methods of making and using them
#30Medicinal aerosols and methods of delivery thereof
#31Delivery of antipsychotics through an inhalation route
#32SOLID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES
#33LIQUID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES
#34Smoker's requisite
#35COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#36PRESSURISED METERED DOSE INHALERS (MDI)
#37Treatment and prevention of vascular dementia
#38Delivery of drug esters through an inhalation route
#39Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining
#40Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
#41Particles for inhalation having sustained release properties
#42Delivery of opioids through an inhalation route
#43Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
#44COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS
#45Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#46Thin-film drug delivery article and method of use
#47Rapid-heating drug delivery article and method of use
#48Delivery of muscle relaxants through an inhalation route
#49Delivery of antihistamines through an inhalation route
#50Delivery of sedative-hypnotics through an inhalation route
#51Delivery of antipsychotics through an inhalation route
#52Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
#53Delivery of diazepam through an inhalation route
#54Treating pulmonary disorders with gaseous agent causing repletion of GSNO
#55Delivery of drug esters through an inhalation route
#56Delivery of caffeine through an inhalation route
#57Delivery of erectile dysfunction drugs through an inhalation route
#58Delivery of analgesics through an inhalation route
#59Delivery of physiologically active compounds through an inhalation route
#60Delivery of diphenhydramine through an inhalation route
#61Delivery of anti-migraine compounds through an inhalation route
#62Method for treating a mammal by administration of a compound having the ability to release CO
#63Delivery of antidepressants through an inhalation route
#64Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
#65Delivery of compounds for the treatment of headache through an inhalation route
#66Delivery of compounds for the treatment of Parkinson's through an inhalation route
#67Delivery of beta-blockers through an inhalation route
#68Treatment of mucosal membranes
#69Delivery of antiemetics through an inhalation route
#70Delivery of stimulants through an inhalation route
#71Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#72Therapeutic treatments using the direct application of antimicrobial metal compositions
#73DRI nasal sprays
#74Use of mometasone furoate for treating airway passage and lung disease
#75Treatment of inflammatory skin conditions
#76Cerebral protection with a gas comprising xenon
#77Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
#78Aerosol formulations containing P134a and particulate medicament
#79Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
#80Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
#81Pressurised metered dose inhalers (MDI)
#82Dry powders of metal-containing compounds
#83Method for the accelerated in vivo removal of ethanol
#84Delivery of sedative-hypnotics through an inhalation route
#85Aerosol formulations and aerosol delivery of scopolamine
#86Delivery of opioids through an inhalation route
#87Medicaments for asthma treatment